Inventor · disambiguated record
Hervé Poras
Also filed as: PORAS HERVE · PORAS HERVÉ
12 granted patents·4 pending applications·16 citations·filing 2001–2023
85Inventor score
Files withPHARMALEADS9MICHEL JEAN-BAPTISTE2FOURNIE-ZALUSKI MARIE-CLAUDE1KOS THERAPEUTICS INC1PORAS HERVE1
Top patents by PatentIndex Score
16 records- 0180US8703747B2Aminophosphinic derivatives that can be used in the treatment of painROQUES BERNARD·Filed 2009·Granted Apr 22, 2014·4 cites·8 claims
- 0276US11648231B2Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve painPHARMALEADS·Filed 2019·Granted May 16, 2023·1 cites·14 claims
- 0372US9388129B2Mixed inhibitors of aminopeptidase N and neprilysinPHARMALEADS·Filed 2013·Granted Jul 12, 2016·2 cites·22 claims
- 0471US8466309B2Amino acid derivatives, method for preparing same, and therapeutic use thereofFOURNIE-ZALUSKI MARIE-CLAUDE·Filed 2009·Granted Jun 18, 2013·3 cites·19 claims
- 0569US11090317B2Aminophosphinic derivatives for preventing and treating eye inflammationPHARMALEADS·Filed 2018·Granted Aug 17, 2021·1 cites·20 claims
- 0669US10131681B2Aminophosphinic derivatives that can be used in the treatment of painPHARMALEADS·Filed 2014·Granted Nov 20, 2018·1 cites·15 claims
- 0766US6716852B2Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitorsSERVIER LAB·Filed 2001·Granted Apr 6, 2004·4 cites·26 claims
- 0862US12485104B2Amino acid derivatives containing a disulfanyl group as an inhibitor of NEP and APN for the prevention and treatment of trigeminal nerve painKOS THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·0 cites·18 claims
- 0949US2022289668A1N-formylhydroxylamines as neprilysin (nep) inhibitors, in particular as mixed aminopeptidase n (apn) and neprilysin (nep) inhibitorsPHARMALEADS·Filed 2020·Application pending·0 cites
- 1045US2018344753A1Aminophosphinic derivatives for preventing and treating eye painPHARMALEADS·Filed 2016·Application pending·0 cites
- 1144US10688113B2Methods of treating eye pain with aminophosphinic derivativesPHARMALEADS·Filed 2019·Granted Jun 23, 2020·0 cites·20 claims
- 1241US9272054B2Agents for the molecular imaging of serine-protease in human pathologiesMICHEL JEAN-BAPTISTE·Filed 2011·Granted Mar 1, 2016·0 cites·20 claims
- 1340US2016206762A1Agents for the Molecular Imaging of Serine-Protease in Human PathologiesMICHEL JEAN-BAPTISTE·Filed 2016·Application pending·0 cites
- 1439US2013203097A1Substrates the fluorescence of which is suppressed, preparation thereof, and use thereof for identifying, detecting, and assaying legionella pneumophiliaPORAS HERVE·Filed 2011·Application pending·0 cites
- 1535US12391710B2Method for the industrial preparation of the disodium salt of ((2S)-3-([1,1′-biphenyl]-4-yl-2-((hydroxy((1R)-1-(((1-(isobutyryloxy)ethoxy)carbonyl)amino)ethyl)phosphoryl) methyl)propanoyl)-l-alaninePHARMALEADS·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 1631US10399936B2Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate saltPHARMALEADS·Filed 2016·Granted Sep 3, 2019·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Hervé Poras files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →